Delivery Order SPE2DB24D2213-SPE2DB25FGXPK
- Not listed
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,868.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work is to be performed at...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,318.60 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-DIP) in 0.5mL dosage. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a time-sensitive pharmaceutical procurement fulfilled from the vendor's location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $10,757.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. The order is scheduled for completion by September 22, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under an existing contract vehicle and does not utilize a set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,739.98 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (A-C-Y-W-135-diphtheria) 0.5 mL vaccine product. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency awarded a $152,714.53 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a $237,587.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (meningococcal conjugate vaccine) with completion targeted for August 27, 2025. This non-set-aside award, issued on August 26, 2025, represents a single delivery order fulfillment from AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $157,016.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine product, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB24D2213Indefinite Delivery Contract
- SPE2DB24D2213-SPE2DB25FGXPKDelivery Order
The Defense Logistics Agency awarded a $7,318.20 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (1 vial-A-C-Y-W-135-DIP 0.5ML) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order executes under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for Menveo vaccine supports the Defense Logistics Agency's mission to supply medical products to military healthcare programs worldwide, reflecting the company's established capability to meet federal procurement requirements for pharmaceutical and vaccine distribution to defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/19/25 |